MIM
WVE icon

MetLife Investment Management’s Wave Life Sciences WVE Stock Holding History

MetLife Investment Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$553K Buy
76,265
+11,502
+18% +$150K ﹤0.01% 1699
2025
Q4 		$1.1M Buy
64,763
+5,557
+9% +$56.5K 0.01% 1371
2025
Q3 		$433K Sell
59,206
-8,051
-12% -$65.1K ﹤0.01% 1874
2025
Q2 		$437K Buy
67,257
+11,854
+21% +$78.3K ﹤0.01% 1740
2025
Q1 		$448K Sell
55,403
-538
-1% -$5.88K ﹤0.01% 1780
2024
Q4 		$692K Buy
55,941
+12,340
+28% +$165K ﹤0.01% 1611
2024
Q3 		$358K Hold
43,601
– – ﹤0.01% 1970
2024
Q2 		$218K Buy
43,601
+5,533
+15% +$31.6K ﹤0.01% 2189
2024
Q1 		$235K Buy
38,068
+6,645
+21% +$33.3K ﹤0.01% 2103
2023
Q4 		$159K Buy
+31,423
New +$168K ﹤0.01% 2366
2023
Q3 		– Sell
-31,423
Closed -$114K – 2988
2023
Q2 		$114K Buy
+31,423
New +$127K ﹤0.01% 2594
2021
Q1 		– Sell
-15,877
Closed -$125K – 2335
2020
Q4 		$125K Buy
15,877
+4,652
+41% +$39K ﹤0.01% 2198
2020
Q3 		$95.3K Buy
11,225
+367
+3% +$4.02K ﹤0.01% 2223
2020
Q2 		$113K Hold
10,858
– – ﹤0.01% 2201
2020
Q1 		$102K Hold
10,858
– – ﹤0.01% 2072
2019
Q4 		$87K Hold
10,858
– – ﹤0.01% 2273
2019
Q3 		$223K Buy
10,858
+2,287
+27% +$52.4K ﹤0.01% 1881
2019
Q2 		$224K Hold
8,571
– – ﹤0.01% 1965
2019
Q1 		$333K Buy
+8,571
New +$348K ﹤0.01% 1701

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

MetLife Investment Management's WVE Position: Q1 2026 in Review

MetLife Investment Management increased its Wave Life Sciences (WVE) stake by 18% in Q1 2026, buying an estimated $150K and bringing the position to 76,265 shares worth $553K. The position accounts for ﹤0.01% of the portfolio, ranked #1699.

MetLife Investment Management first reported a position in WVE in Q1 2019 and has held it in 19 quarters since. The position peaked at $1.1M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • MetLife Investment Management held 76,265 shares of Wave Life Sciences worth $553K as of Q1 2026.
  • MetLife Investment Management bought 11,502 Wave Life Sciences shares in Q1 2026, an estimated $150K.
  • Wave Life Sciences made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1699 holding.
  • MetLife Investment Management first reported a position in Wave Life Sciences in Q1 2019 and has held it in 19 quarters since.
  • MetLife Investment Management's Wave Life Sciences position peaked at $1.1M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.